Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "New Challenges in Radiochemistry"
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (31 August 2016).
It was in 1930 that E.O. Lawrence developed the first particle accelerator and revolutionized the scientific world. Since then, this technology has allowed science to make considerable progress in the understanding of matter and the universe (LHC, CERN).
The use of a cyclotron provides access to a variety of synthetic radioisotopes. These were first used for therapeutic applications in medicine. Then, the chemistry of metal–ligand complexes has allowed the development of imaging in nuclear medicine. Finally, more recently, the use of positron emitting radionuclides in relation with the coming of Positron Emission Tomography (PET). The use of compounds labeled with dedicated radioactive tracers made it possible to explore another dimension of nuclear medicine imaging: That of the observation of the functioning of organs in living beings dynamically, non-invasively and without physiological effects. All this would not have been possible without all the dramatic improvements in chemical synthesis strategies acquired these past thirty years.
The aim of this Special Issue of Pharmaceuticals is to report a review of the state of the art of radiochemistry. What are the impacts on new drugs, medical diagnoses, and treatment monitoring of diseases?
Dr. Michel Monclus
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- automated synthesis